[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_85 

# __Decrease in case growth rate__

## Articles mentionning this Benefit

* [Effectiveness of non-pharmaceutical public health interventions against COVID-19: A systematic review and meta-analysis](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_19.md)

## Category to which it belongs

* [Improved outcomes, reduced vulnerability, and enhanced efficiency are achieved through a variety of measures and interventions.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_18.md)

## Description of actual returns pertaining to this benefit

* [Private investors investing in early enforcement of lockdown would benefit from a decreased risk of infection, potential reduction in healthcare costs, and improved economic stability.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_84.md)
* [Private investors investing in nphis would benefit from a decreased risk of infection, potential reduction in healthcare costs, and improved economic stability.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_85.md)

## Name of the Benefit

NPHIs have resulted in a 4.86% decrease in daily case growth rate, reducing transmission of the virus.

## Risks which can benefit from this action

* [Early enforcement of lockdown](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_74.md)
* [Non-pharmaceutical public health interventions nphis](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_75.md)

## Stakeholders benefitting from this Benefit

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)

